Novo plots Victoza launches in Germany, U.K.

Armed with European approval for its new diabetes treatment Victoza, Novo Nordisk plans a launch this summer in Britain, Germany and Denmark, with other European markets to follow. The company is still awaiting FDA's blessing after thyroid safety questions prompted questions from an expert advisory panel. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.